大麻中毒不会影响小烧伤患者的营养状况
Sarah Wang1, Eloise Stanton2, Amara Emeh1
1Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
概括
在烧伤患者中使用大麻并没有显著影响营养状况或康复结果. 这项研究发现,大麻中毒与烧伤幸存者的前白蛋白或白蛋白水平之间没有联系.
科学领域:
- 医学研究 医学研究
- 营养科学 营养科学
- 创伤护理 创伤护理
背景情况:
- 烧伤患者经历严重的高代谢,增加营养不良的风险和影响恢复.
- 大麻以食欲刺激而闻名,但其在烧伤患者营养中的作用尚不清楚.
- 了解营养影响对于改善烧伤护理结果至关重要.
研究的目的:
- 调查大麻使用与成年烧伤患者营养状况之间的关联.
- 为了确定大麻中毒是否会影响关键的营养标记物,如前白蛋白和白蛋白.
- 探索大麻使用与患者烧伤后伤害结果之间的关系.
主要方法:
- 对2015-2024年期间入院的成年烧伤患者 (<20%的TBSA) 的回顾性研究.
- 匹配的1:1比较大麻阳性患者与大麻阴性对照.
- 对人口统计,烧伤特征,营养标记 (前白蛋白,白蛋白) 和结果的分析.
主要成果:
- 大麻使用者和对照人群之间在人口统计或结果方面没有显著差异.
- 大麻中毒与入院前的专蛋白或专蛋白水平没有显著的关联.
- 没有观察到达到峰值前专辑蛋白或专辑蛋白水平的时间有显著变化.
结论:
- 大麻中毒似乎不会显著影响入院时烧伤患者的营养状况.
- 需要对更大群体进行进一步的研究,以充分阐明大麻和烧伤恢复之间的复杂关系.
- 发现年龄和种族与白蛋白水平有关,突出了影响营养状况的其他因素.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
806
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
806
Burn Injuries
4.7K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.7K
CNS Depressants: Alcohol and Nicotine
1.4K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
285
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
285
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Toxicity: Risk factors
27
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
27


